Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
35.61
-1.75 (-4.68%)
At close: Apr 1, 2025, 4:00 PM
35.10
-0.51 (-1.43%)
Pre-market: Apr 2, 2025, 4:38 AM EDT

Apogee Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,0682,5781,342-
Market Cap Growth
92.14%92.14%--
Enterprise Value
1,3491,836919-
Last Close Price
35.6145.3027.94-
PB Ratio
2.883.603.53-
P/TBV Ratio
3.603.603.53-
Debt / Equity Ratio
0.020.020.01-
Quick Ratio
18.4018.4019.3015.22
Current Ratio
18.5518.5519.3815.24
Return on Equity (ROE)
-33.22%-33.22%-32.18%-
Return on Assets (ROA)
-23.46%-23.46%-21.00%-
Return on Capital (ROIC)
-24.41%-24.41%-22.18%-
Earnings Yield
-8.81%-7.07%-6.26%-
FCF Yield
-8.33%-6.69%-5.58%-
Buyback Yield / Dilution
-120.72%-120.72%-915.57%-
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q